Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T16:37:20.850Z.
Calculation as of: 2026-10-06T16:37:20.850Z.
Quote observation: 2026-10-06T16:32:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 76b79f67d555c15c1d19b9a53ec9076b1294dcb64452140a50102a9ec63499e7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2016-11-14.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$7.95M
EV/Sales Ratio
N/A
TTM Avg
1162726.42x
3Y Avg
640219.29x
5Y Avg
640219.29x
Market Cap
$8.06M
EV/Sales Ratio
N/A
TTM Avg
4.01x
3Y Avg
4.01x
5Y Avg
4.01x
Market Cap
$8.19M
EV/Sales Ratio
N/A
TTM Avg
802.02x
3Y Avg
903.36x
5Y Avg
873.57x
Market Cap
$8.45M
EV/Sales Ratio
0.76x
TTM Avg
0.33x
3Y Avg
0.31x
5Y Avg
0.34x
Market Cap
$7.31M
EV/Sales Ratio
0.00x
TTM Avg
0.29x
3Y Avg
0.29x
5Y Avg
1.64x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $7.97M | N/A | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | N/A | 1162726.42x | 640219.29x | 640219.29x |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.06M | N/A | 4.01x | 4.01x | 4.01x |
| HeartSciences Inc. (HSCS)vs › | $8.19M | N/A | 802.02x | 903.36x | 873.57x |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.59M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.42M | 4.81x | 2.16x | 2.16x | 2.16x |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.45M | 0.76x | 0.33x | 0.31x | 0.34x |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.34M | N/A | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 0.00x | 0.29x | 0.29x | 1.64x |
| Skye Bioscience, Inc. (SKYE)vs › | $7.25M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2016-11-14 | 4677.45x |
| 2016-11-11 | 4542.23x |
| 2016-11-10 | 4138.35x |
| 2016-11-09 | 4875.79x |
| 2016-11-08 | 5011.01x |
| 2016-11-07 | 4677.45x |
| 2016-11-04 | 4407.00x |
| 2016-11-03 | 4303.32x |
| 2016-11-02 | 4176.77x |
| 2016-11-01 | 4452.07x |
| 2016-10-31 | 4632.38x |
| 2016-10-28 | 4677.45x |
| 2016-10-26 | 4722.53x |
| 2016-10-25 | 4808.16x |
| 2016-10-24 | 4722.53x |
| 2016-10-20 | 5038.06x |
| 2016-10-19 | 4947.91x |
| 2016-10-18 | 4767.60x |
| 2016-10-13 | 4767.60x |
| 2016-10-12 | 4858.88x |
| 2016-10-11 | 5128.21x |
| 2016-10-10 | 5178.96x |
| 2016-10-04 | 5038.06x |
| 2016-09-12 | 5308.51x |
| 2016-09-06 | 5146.24x |
| 2016-08-29 | 5047.07x |
| 2016-08-26 | 5173.29x |
| 2016-08-24 | 5398.66x |
| 2016-08-18 | 5460.87x |
| 2016-08-17 | 5493.32x |
| 2016-08-16 | 5939.57x |
| 2016-08-15 | 5488.82x |
| 2016-08-12 | 5218.36x |
| 2016-08-09 | 636.04x |
| 2016-08-08 | 640.07x |
| 2016-08-04 | 628.99x |
| 2016-08-03 | 611.85x |
| 2016-08-02 | 610.85x |
| 2016-08-01 | 630.00x |
| 2016-07-29 | 650.15x |
| 2016-07-28 | 650.66x |
| 2016-07-27 | 710.63x |
| 2016-07-26 | 730.69x |
| 2016-07-25 | 771.10x |
| 2016-07-22 | 778.12x |
| 2016-07-21 | 773.42x |
| 2016-07-20 | 781.18x |
| 2016-07-19 | 761.02x |
| 2016-07-18 | 761.02x |
| 2016-07-15 | 781.18x |
| 2016-07-14 | 778.04x |
| 2016-07-13 | 781.08x |
| 2016-07-12 | 776.14x |
| 2016-07-11 | 766.06x |
| 2016-07-08 | 786.22x |
| 2016-07-07 | 791.26x |
| 2016-07-06 | 791.26x |
| 2016-07-05 | 811.42x |
| 2016-06-30 | 821.50x |
| 2016-06-29 | 796.30x |
| 2016-06-28 | 791.26x |
| 2016-06-27 | 811.42x |
| 2016-06-24 | 851.73x |
| 2016-06-23 | 851.73x |
| 2016-06-22 | 821.50x |
| 2016-06-21 | 866.45x |
| 2016-06-20 | 791.26x |
| 2016-06-17 | 779.17x |
| 2016-06-16 | 811.42x |
| 2016-06-14 | 826.44x |
| 2016-06-09 | 793.78x |
| 2016-06-07 | 861.81x |
| 2016-03-29 | 911.78x |
| 2016-03-28 | 1005.12x |
